Cargando…
Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19
Self-adjuvanting protein vaccines have been proved to be highly immunogenic with efficient codelivery of adjuvant and antigen. Current protein vaccines with built-in adjuvants are all modified at the peptide backbone of antigen protein, which could not achieve minor epitope interference and adjuvant...
Autores principales: | Wen, Yu, Zhang, Ru-Yan, Wang, Jian, Zhou, Shi-Hao, Peng, Xiao-Qian, Ding, Dong, Zhang, Zhi-Ming, Wei, Hua-Wei, Guo, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907060/ https://www.ncbi.nlm.nih.gov/pubmed/36716860 http://dx.doi.org/10.1016/j.jconrel.2023.01.062 |
Ejemplares similares
-
Sialoglycans and genetically engineered plants
por: Ghosh, Shyamasree
Publicado: (2020) -
Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses
por: Du, Jing-Jing, et al.
Publicado: (2020) -
Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10
por: Forgione, Rosa Ester, et al.
Publicado: (2020) -
Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10
por: Forgione, Rosa Ester, et al.
Publicado: (2020) -
Sialoglycan recognition is a common connection linking acidosis, zinc, and HMGB1 in sepsis
por: Siddiqui, Shoib S., et al.
Publicado: (2021)